E-LIB Suche - Ergebnisse für: Jonathan Corren

1

Efficacy of Tezepelumab in Patients With Severe, Uncontroll..:

Corren, Jonathan ; Mathur, Sameer K. ; Carr, Tara F....
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB97 , 2024

Link: https://doi.org/10.1016/..

2

Dupilumab Reduces Exacerbations Independent of Changes in B..:

Pavord, Ian D. ; Casale, Thomas B. ; Corren, Jonathan...
The Journal of Allergy and Clinical Immunology: In Practice. 12 (2024) 7 - p. 1763-1772 , 2024

Link: https://doi.org/10.1016/..

3

Differential modulation of allergic rhinitis nasal transcri..:

Wipperman, Matthew F. ; Gayvert, Kaitlyn M. ; Atanasio, Amanda...
Allergy. 79 (2024) 4 - p. 894-907 , 2024

Link: https://doi.org/10.1111/..

4

Dupilumab sustains lung function improvements in patients w..:

Papi, Alberto ; Castro, Mario ; Corren, Jonathan...
Respiratory Medicine. 224 (2024) - p. 107535 , 2024

Link: https://doi.org/10.1016/..

5

Biomarkers and clinical outcomes after tezepelumab cessatio:

Brightling, Christopher E. ; Caminati, Marco ; Llanos, Jean-Pierre...
Annals of Allergy, Asthma & Immunology. , 2024

Link: https://doi.org/10.1016/..

6

Tezepelumab for Severe Asthma: One Drug Targeting Multiple ..:

Panettieri Jr, Reynold ; Lugogo, Njira ; Corren, Jonathan.
Journal of Asthma and Allergy. 17 (2024) - p. 219-236 , 2024

Link: https://doi.org/10.2147/..

7

Impact of dupilumab across seasons in patients with type 2,..:

Peters, Anju T. ; Sagara, Hironori ; Corren, Jonathan...
Annals of Allergy, Asthma & Immunology. 132 (2024) 4 - p. 477-484.e4 , 2024

Link: https://doi.org/10.1016/..

8

Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-D..:

Corren, Jonathan ; Szefler, Stanley J. ; Sher, Ellen...
The Journal of Allergy and Clinical Immunology: In Practice. 12 (2024) 5 - p. 1215-1224.e3 , 2024

Link: https://doi.org/10.1016/..

9

The combination of allergen immunotherapy and biologics for..:

Olivieri, Bianca ; Günaydın, Fatma Esra ; Corren, Jonathan..
Annals of Allergy, Asthma & Immunology. , 2024

Link: https://doi.org/10.1016/..

10

Tezepelumab Reduces Exacerbations Across All Seasons In Pat..:

Corren, Jonathan ; Lindsley, Andrew ; Spahn, Joseph...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB194 , 2023

Link: https://doi.org/10.1016/..

11

Lebrikizumab Decreases Inflammatory Biomarkers in Patients ..:

Szefler, Stanley ; Corren, Jonathan ; Silverberg, Jonathan...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB195 , 2023

Link: https://doi.org/10.1016/..

12

Dupilumab Efficacy in Patients with Type 2 Asthma with and ..:

Bleecker, Eugene R. ; Panettieri Jr., Reynold A. ; Lugogo, Njira L....
Journal of Immunology Research. 2023 (2023) - p. 1-11 , 2023

Link: https://doi.org/10.1155/..

13

Effect of tezepelumab on healthcare utilization in patients..:

Menzies-Gow, Andrew ; Bourdin, Arnaud ; Chupp, Geoffrey...
Annals of Allergy, Asthma & Immunology. 131 (2023) 3 - p. 343-348.e2 , 2023

Link: https://doi.org/10.1016/..

14

Tezepelumab in patients with allergic and eosinophilic asth..:

Caminati, Marco ; Buhl, Roland ; Corren, Jonathan...
Allergy. 79 (2023) 5 - p. 1134-1145 , 2023

Link: https://doi.org/10.1111/..

15

Dupilumab Efficacy in Patients with Uncontrolled Moderate-t..:

Corren, Jonathan ; Jackson, David J ; Casale, Thomas B...
Journal of Asthma and Allergy. 16 (2023) - p. 249-260 , 2023

Link: https://doi.org/10.2147/..